Literature DB >> 11051290

Chromium supplementation improves insulin resistance in patients with Type 2 diabetes mellitus.

B W Morris, S Kouta, R Robinson, S MacNeil, S Heller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11051290     DOI： 10.1046/j.1464-5491.2000.00342.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  6 in total

1.  Conjugated linoleic acid and chromium lower body weight and visceral fat mass in high-fat-diet-fed mice.

Authors:  Arunabh Bhattacharya; M Mizanur Rahman; Roger McCarter; Marianne O'Shea; Gabriel Fernandes
Journal:  Lipids       Date:  2006-05       Impact factor: 1.880

2.  Chromium Therapy for Insulin Resistance Associated with HIV-Disease.

Authors:  Seth A Stein; Margaret Mc Nurlan; Brett T Phillips; Catherine Messina; Dennis Mynarcik; Marie Gelato
Journal:  J AIDS Clin Res       Date:  2013-09-07

3.  Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.

Authors:  Ansab Akhtar; Jatinder Dhaliwal; Priyanka Saroj; Ankit Uniyal; Mahendra Bishnoi; Sangeeta Pilkhwal Sah
Journal:  Inflammopharmacology       Date:  2020-01-03       Impact factor: 4.473

4.  Chromium picolinate and chromium histidinate protects against renal dysfunction by modulation of NF-κB pathway in high-fat diet fed and Streptozotocin-induced diabetic rats.

Authors:  Mustafa Yavuz Selcuk; Bilge Aygen; Ayhan Dogukan; Zeynep Tuzcu; Fatih Akdemir; James R Komorowski; Mustafa Atalay; Kazim Sahin
Journal:  Nutr Metab (Lond)       Date:  2012-04-08       Impact factor: 4.169

5.  Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity.

Authors:  Umesh Masharani; Christine Gjerde; Shelley McCoy; Betty A Maddux; Danielle Hessler; Ira D Goldfine; Jack F Youngren
Journal:  BMC Endocr Disord       Date:  2012-11-30       Impact factor: 2.763

6.  Combination Treatment of Deep Sea Water and Fucoidan Attenuates High Glucose-Induced Insulin-Resistance in HepG2 Hepatocytes.

Authors:  Shan He; Wei-Bing Peng; Hong-Lei Zhou
Journal:  Mar Drugs       Date:  2018-02-02       Impact factor: 5.118
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.